Safety Considerations for Oligonucleotides |
|
Enduring |
|
$25.00 |
Immuno-oncology |
|
Enduring |
|
$25.00 |
Immuno-oncology |
|
Enduring |
|
$25.00 |
T cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Immunophenotyping |
|
Enduring |
|
$25.00 |
T cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
B cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Systems Biology Applied to Immune Safety |
|
Enduring |
|
$25.00 |
B cell targeting therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Innate immune cell therapies (e.g. activation, inhibition pathways, therapies, toxicities) |
|
Enduring |
|
$25.00 |
Immunogenicity characterization tools (ADAs, complement, immune complexes) |
|
Enduring |
|
$25.00 |
Immunopathology: evaluation, assessment, and considerations |
|
Enduring |
|
$25.00 |
Immunopathology: evaluation, assessment, and considerations |
|
Enduring |
|
$25.00 |